Clinical Trial Update: Aurolab Hydrophobic Foldable Intraocular Lens Study [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating Aurolab's hydrophobic foldable intraocular lens for cataract has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract

Drugs mentioned

• Aurolab Hydrophobic Foldable Intraocular Lens

Snippet

Sponsor: Aurolab | Conditions: Cataract | Phase 4 | Status: COMPLETED